An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype

Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up

NCT01884220 ·Status: COMPLETED

Identification of Undiagnosed Lysosomal Acid Lipase Deficiency

NCT01716728 ·Status: UNKNOWN ·Phase: NA

Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids

NCT00328159 ·Status: COMPLETED ·Phase: NA

Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program

NCT03768817 ·Status: COMPLETED

An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency

NCT02376751 ·Status: NO_LONGER_AVAILABLE

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

NCT02214160 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH)

NCT02650115 ·Status: COMPLETED

Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)

NCT02598128 ·Status: COMPLETED ·Phase: NA

Intralumenal Effects on Cholesterol Absorption/Synthesis

NCT00328211 ·Status: COMPLETED ·Phase: NA

Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression

NCT05291104 ·Status: COMPLETED ·Phase: NA

Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity

NCT03564002 ·Status: UNKNOWN

Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)

NCT00571272 ·Status: SUSPENDED

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

NCT03312140 ·Status: COMPLETED ·Phase: NA

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

NCT05720702 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Hepatic Histopathology in Urea Cycle Disorders

NCT04908319 ·Status: RECRUITING

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

NCT01865812 ·Status: COMPLETED ·Phase: PHASE2

Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia

NCT00004353 ·Status: COMPLETED

The Natural History of Mucolipidosis Type IV

NCT01067742 ·Status: TERMINATED

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

NCT00004441 ·Status: COMPLETED ·Phase: NA

Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life

NCT01008293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency

NCT04147936 ·Status: COMPLETED ·Phase: NA

Study of Bile Acids in Patients With Peroxisomal Disorders

NCT00004442 ·Status: TERMINATED ·Phase: NA

Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency

NCT00006061 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)

NCT05499026 ·Status: COMPLETED